GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Short-Term Debt

Ascelia Pharma AB (OSTO:ACE) Short-Term Debt : kr0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Short-Term Debt?

Ascelia Pharma AB's Short-Term Debt for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Ascelia Pharma AB Short-Term Debt Historical Data

The historical data trend for Ascelia Pharma AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Short-Term Debt Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial - - - - -

Ascelia Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ascelia Pharma AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Ascelia Pharma AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Short-Term Debt
Comparable Companies
XSAT:CESSA OSTO:NXTCL OSTO:LIPUM OSTO:SIMRIS B OSTO:BIOVIC B OSTO:ALZ OSTO:ZICC OSTO:ELIC NGM:GTAB B OSTO:XINT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
7ZA:Germany
Address
Hyllie Boulevard 34, Malmo, SWE, SE-215 32
Website
https://www.ascelia.com
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines